J. Miyakawa, “Impact of Monthly 120 Mg Denosumab on Bone Metabolism in Bone-metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy”, apjcc, vol. 2, no. 3, pp. 41-46, Jun. 2017.